Molecules with specificity for CD45 and CD79

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10774152
APP PUB NO 20170204183A1
SERIAL NO

15326499

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a multispecific molecule comprising a binding domain specific to the antigen CD45 and a binding domain specific to the antigen CD79a and/or CD79b, compositions comprising same and use of each in treatment, for example treatment of autoimmune disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB BIOPHARMA SRLALLEE DE LA RECHERCHE 60 BRUSSELS B-1070

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Finney, Helene Margaret Slough, GB 33 773
Rapecki, Stephen Edward Slough, GB 46 270
Tyson, Kerry Louise Slough, GB 62 725
Wright, Michael John Slough, GB 26 220

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 15, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 15, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00